Your decision, not a generic summary.
An ingredient-development team needs a study that answers a useful scientific question and an interpretation that respects the model. The source map identifies this buyer group because the task is concrete: evaluate activity, choose the next study or understand what a proposed claim still needs. It does not establish that any named brand is a Karam client.
Where a scoped engagement can help.
Before commissioning testing
Specify the ingredient, model, intended activity and decision. Establish how the result would influence development.
When interpreting an early result
Keep the cell or other research-model observation distinct from human efficacy.
Before broader claims
Identify the additional substantiation and specialist review the actual claim requires.
What to bring.
A nonconfidential ingredient summary, rights to the material, existing evidence, intended use, proposed claims and a budget for research and review.
How to compare a proposal.
Compare model relevance, raw-data access, repeat policy, interpretation quality and claims boundaries. A low-cost assay with no usable handover may not answer the development question.
Example inquiry: “Our ingredient changes a cell marker. What would a credible next study establish, and what can we not yet say?”